Table 1.
Baseline clinical and demographic data of the two study groups.
| Non-Renal Loss Group (n = 421) |
Renal Loss Group (n = 15) |
p-value | |
|---|---|---|---|
| Age at diagnosis (years) | 35.1 (32; 37) | 33.8 (28; 38) | 0.16 |
| Body mass index (Kg/m2) | 22.4 (21.1; 24.3) | 22.6 (20.3; 25.6) | 0.92 |
| Infertility | 173 (41.1) | 12 (80.0) | 0.003 |
| Previous endometriosis surgery | 349 (82.8) | 10 (66.7) | 0.47 |
| Previous non-endometriosis surgery | 232 (55.1) | 10 (66.7) | 0.40 |
| Previous hormonal treatment | 240 (57.0) | 8 (53.3) | 0.77 |
| Asymptomatic | 25 (5.9) | 4 (26.7) | 0.002 |
| Pain symptoms | |||
| Dysmenorrhea (NRS ≥ 7) | 280 (66.5) | 12 (80.0) | 0.29 |
| Chronic pelvic pain (NRS ≥ 7) | 117 (27.8) | 3 (20.0) | 0.49 |
| Dyspareunia (NRS ≥ 7) | 109 (25.9) | 0 (0.0) | 0.06 |
| Dyschezia (NRS ≥ 7) | 69 (16.4) | 0 (0.0) | 0.14 |
| Dysuria (NRS ≥ 7) | 19 (4.3) | 0 (0.0) | 0.46 |
Results are expressed as median (25th; 75th percentiles) or n (%).
NRS numerical rating scale.